Seer (SEER) Current Deferred Revenue (2020 - 2026)

Seer (SEER) posted quarterly Current Deferred Revenue of $334000.0 for Q1 2026, down 24.6% year-over-year from $443000.0 in Q1 2025, and down 2.05% quarter-over-quarter from $341000.0 in Q4 2025.

Seer (SEER) Current Deferred Revenue (2020 - 2026) Analysis & Trends

Seer's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $334000.0 for Q1 2026.

  • In Q1 2026, Current Deferred Revenue fell 24.6% year-over-year to $334000.0; the TTM figure through Mar 2026 stood at $334000.0 (down 24.6% YoY), while the FY2025 annual figure was $341000.0, down 25.22% from the prior year.
  • Current Deferred Revenue for Q1 2026 stood at $334000.0, down from $341000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $540000.0 in Q2 2025, with the low at $133000.0 in Q1 2022.
  • The 5-year median for Current Deferred Revenue is $329000.0 (2024), against an average of $335058.8.
  • The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue plunged 64.63% in 2022, then soared 132.76% in 2025.
  • Seer's Current Deferred Revenue stood at $133000.0 in 2022, then jumped by 103.01% to $270000.0 in 2023, then soared by 68.89% to $456000.0 in 2024, then declined by 25.22% to $341000.0 in 2025, then declined by 2.05% to $334000.0 in 2026.
  • Business Quant data shows SEER's Current Deferred Revenue at $334000.0 in Q1 2026, $341000.0 in Q4 2025, and $496000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Seer 230.63 Mn 230.63 Mn 1.51 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 387,000.00
Mar 31, 2026 334,000.00
Dec 31, 2025 341,000.00
Sep 30, 2025 496,000.00
Jun 30, 2025 540,000.00
Mar 31, 2025 443,000.00
Dec 31, 2024 456,000.00
Sep 30, 2024 413,000.00
Jun 30, 2024 232,000.00
Mar 31, 2024 329,000.00
Dec 31, 2023 270,000.00
Sep 30, 2023 230,000.00
Jun 30, 2023 286,000.00
Mar 31, 2023 306,000.00
Dec 31, 2022 133,000.00
Sep 30, 2022 325,000.00
Jun 30, 2022 429,000.00
Mar 31, 2022 133,000.00
Dec 31, 2021 376,000.00
Sep 30, 2021 376,000.00